ASTHMAPHARMA

Serial Number 79016184
402

Registration Progress

Application Filed
Jun 27, 2005
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

ASTHMAPHARMA

Basic Information

Serial Number
79016184
Filing Date
June 27, 2005
Abandonment Date
June 28, 2015
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
402
Status Date
Jun 28, 2015

Rights Holder

FARMALIDER, S.A.

99
Address
Arequipa, 1
E-28043 MADRID
ES

Ownership History

FARMALIDER, S.A.

Original Applicant
99
ES

Legal Representation

Attorney
HORST M KASPER

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

25 events
Date Code Type Description
Jan 15, 2016 DENA O NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jan 14, 2016 DETH P DEATH OF INTERNATIONAL REGISTRATION
Jun 19, 2014 NREP P NEW REPRESENTATIVE AT IB RECEIVED
May 23, 2008 FINT P FINAL DECISION TRANSACTION PROCESSED BY IB
May 6, 2008 FICS P FINAL DISPOSITION NOTICE SENT TO IB
May 5, 2008 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 3, 2007 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 3, 2007 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 26, 2007 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 5, 2007 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 5, 2007 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 4, 2006 CNFR O FINAL REFUSAL MAILED
Oct 3, 2006 CNFR R FINAL REFUSAL WRITTEN
Sep 23, 2006 ACEC I AMENDMENT FROM APPLICANT ENTERED
Jul 24, 2006 MAIL I PAPER RECEIVED
Jul 24, 2006 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2006 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 1, 2006 MAIL I PAPER RECEIVED
Feb 3, 2006 RFNT P REFUSAL PROCESSED BY IB
Jan 19, 2006 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 19, 2006 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 18, 2006 DOCK D ASSIGNED TO EXAMINER
Jan 18, 2006 CNRT R NON-FINAL ACTION WRITTEN
Nov 7, 2005 NWAP I NEW APPLICATION ENTERED
Nov 3, 2005 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Additional Information

Pseudo Mark
ASTHMA PHARMACEUTICAL